A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2004
12/16/2004	WO2004093883A3 Sachet for a pharmaceutical composition
12/16/2004	WO2004089414A3 Combinations of proton pump inhibitors or blockers with prokinetic agents
12/16/2004	WO2004080961A3 Crystalline and amorphous solids of pantoprazole and processes for their preparation
12/16/2004	WO2004047737A3 Nucleotide based medicament and method of use for treatment of conditions in humans
12/16/2004	WO2004035740A3 Aromatic bicyclic heterocyles to modulate 1l - 12 production
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254377 Novel processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254248 In mouth, mucous membranes; using citric acid salt or succinic acid salt as wound healing agents
12/16/2004	US20040254244 Agent for prophylaxis or treatment of inflammatory bowel diseases
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254223 Process for the preparation of amorphous form of torsemide
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254184 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
12/16/2004	US20040254183 Pyrazolo[3,4-d]pyrimidines inhibiting h. pylori infections
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254128 Treatment and prevention of heat shock protein-associated diseases and conditions
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders
12/16/2004	US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253226 administering to the animals angiogenesis inhibitors comprising kallikreins such as prostate specific antigens (PSA), hydrolase enzymes homologs or fragments; prophylaxis of cancer, arthritis and vision defects
12/16/2004	US20040253193 metronidazole and nystatin with a carrier; mouthwash
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
12/15/2004	EP1486214A1 Botulinum toxins for treating muscle spasm
12/15/2004	EP1486210A1 Pyrimidine nucleotide precursors for treatment of inflammatory hepatitis
12/15/2004	EP1486209A2 Pharmaceutical formulations for the treatment of inflammatory bowel disease
12/15/2004	EP1485492A2 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta(1,4)-n-acetylglucosaminyltransferase iii) expression in plants
12/15/2004	EP1485390A1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/15/2004	EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485373A1 Method of stabilizing lansoprazole
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485368A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485127A2 Administration of agents for the treatment of inflammation
12/15/2004	EP1485118A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy
12/15/2004	EP1485111A1 Compositions containing labile bioactive materials and mammalian colostrum, methods of preparation and treatment
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485087A1 (+)-2- 1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
12/15/2004	EP1485086A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane as nmda, 5ht3, and neuronal nicotinic receptor antagonists
12/15/2004	EP1485085A1 Phosphate prodrugs of fluorooxindoles
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
12/15/2004	EP1485074A2 Compositions for treating digestive functional pathologies
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1399155A4 Small molecules useful in the treatment of inflammatory disease
12/15/2004	EP1373216B1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/15/2004	EP1368303B1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1283056B1 Medicinal compositions promoting bowel movement
12/15/2004	EP1263711B1 Novel use of phenylheteroalkylamine derivatives
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1176963B1 Use of dopamine d 3 receptor antagonists for producing medicaments for treating kidney disorders
12/15/2004	EP1149063B1 Ureido-thiobutyric acid derivatives as ppar-agonists
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	EP1091957B1 Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
12/15/2004	EP1068180B1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors
12/15/2004	EP1019488B1 Feed product
12/15/2004	EP0929323B1 Implantable acrylamide copolymer hydrogel for therapeutic uses
12/15/2004	CN1555389A Oral-use polymer and oral-use composition
12/15/2004	CN1555385A Ligands to enhance cellular uptake of biomolecules
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555356A Bisphenol derivative as NHE-3 inhibitor
12/15/2004	CN1555355A Substituted 4-aminocyclohexanol derivatives
12/15/2004	CN1555268A Therapeutic agents comprising pro-apoptotic proteins
12/15/2004	CN1555266A Hormone replacement therapy

1 ... 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 ... 1258